Unknown

Dataset Information

0

Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block.

ABSTRACT:

SUBMITTER: Hockenhull K 

PROVIDER: S-EPMC8512467 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block.

Hockenhull Kimberley K   Ortega-Franco Ana A   Califano Raffaele R  

Translational lung cancer research 20210901 9

Similar Datasets

Unknown Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.
| S-EPMC9988982 | biostudies-literature
Unknown Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer in China.
| S-EPMC10505025 | biostudies-literature
Unknown Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.
| S-EPMC10394135 | biostudies-literature
Unknown Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
| S-EPMC10082300 | biostudies-literature
Unknown Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer.
| S-EPMC6556538 | biostudies-literature
Unknown Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer.
| S-EPMC10559199 | biostudies-literature
Unknown Pembrolizumab plus pemetrexed-platinum for metastatic nonsquamous non-small-cell lung cancer: KEYNOTE-189 Japan Study.
| S-EPMC8353942 | biostudies-literature
Unknown Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
| S-EPMC10640551 | biostudies-literature
Unknown A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancer.
| S-EPMC8088931 | biostudies-literature
Unknown Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
| S-EPMC10766714 | biostudies-literature